Finasteride has a well-established long-term safety record for male pattern hair loss — it's been FDA-approved for this specific use (at 1mg daily) since 1997, and decades of use since then haven't turned up major long-term safety concerns for most men. That doesn't mean it's risk-free for everyone; it means the risks that exist are well-characterized rather than unknown.
What does finasteride actually do?
Finasteride blocks the conversion of testosterone into DHT (dihydrotestosterone), the hormone most directly responsible for the hair follicle shrinkage behind male pattern baldness. Lowering DHT around the scalp is what slows further hair loss and, for many users, allows some regrowth over time.
What are the real side effects to know about?
The most discussed side effects are sexual — reduced libido, erectile difficulty, or changes in ejaculate volume — reported in a minority of users, usually reversible after stopping the medication. There's also an ongoing, genuinely debated discussion in the medical literature about a small subset of men reporting persistent symptoms after stopping (sometimes referred to as "post-finasteride syndrome"), which researchers haven't fully settled. It's rare, but it's worth knowing about before you start, not finding out about after.
Does it need regular monitoring?
Finasteride can lower PSA (prostate-specific antigen) levels, which matters if you're also being screened for prostate cancer — your doctor needs to know you're taking it so PSA results get interpreted correctly, not misread as reassuring when they're actually being suppressed by the medication.
What happens if you stop taking it?
The DHT-driven hair loss it was holding back typically resumes — most of the regrowth benefit gradually reverses over months once you stop, which is why it's generally framed as an ongoing, ideally long-term treatment rather than a short course. That's also exactly why the decision to start it is worth a real conversation with a doctor about your specific history, not just a default "try it and see."